Sarepta Therapeutics (NASDAQ:SRPT)

Sarepta Therapeutics (NASDAQ:SRPT)


Share Price
$ 119.57
Change
-3.64 (-2.95 %)
Market Cap
$8,866.58 m
Proactive Investors - Run By Investors For Investors

Sarepta Therapeutics

Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., is a biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of both rare and infectious diseases.
EPIC: SRPT
Market: NASDAQ:SRPT
52-week High/Low: $176.44 / $95.36
Sector: Health Care, Equipment & Services
Market Cap: $8,866.58 m
Website: www.sareptatherapeutics.com
col 3
col 4
col 5
col 6

Sarepta Therapeutics Timeline

Market Reports Including SRPT

VIEW ALL

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use